Activity of aclidinium bromide, a new long-acting muscarinic antagonist: a phase I study

AIM: Aclidinium bromide is a muscarinic antagonist in development for the treatment of chronic obstructive pulmonary disease (COPD). This phase I trial in healthy subjects investigated the bronchodilator activity of aclidinium and its ability to reduce methacholine-induced bronchoconstriction. METHO...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Schelfhout, Vanessa J, Ferrer, Pau, Jansat, Josep Maria, Peris, Francesc, Gil, Esther Garcia, Pauwels, Romain A, Joos, Guy F
Формат: Artigo
Язык:Inglês
Опубликовано: Blackwell Science Inc 2010
Предметы:
Clinical Trials
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC2856046/
https://ncbi.nlm.nih.gov/pubmed/20573081
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1365-2125.2010.03622.x
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы